TECRP2

Across TCGA pan-cancer cohorts, TECRP2 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated TECRP2 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher TECRP2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TECRP2 expression acts as an unfavorable survival marker, although some lineages such as ACC and DLBC show a favorable association.

OV, LUAD, and MESO are the cancer types where TECRP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Quartile	III,IV	0.301	0.439	.002	82	view →
LUAD	OS	Tertile	II,III,IV	0.611	0.811	.004	51	view →
MESO	DFS	Tertile	II,III,IV	0.122	0.582	<.001	45	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	41	view →
PAAD	OS	Quartile	II,III,IV	0.240	0.423	.003	39	view →
ACC	OS	Quartile	All	0.972	0.740	.006	20	view →
DLBC	DFS	Tertile	All	1.000	0.430	.012	17	view →
UCS	OS	Tertile	IV	0.844	0.244	.019	12	view →
THCA	DFS	Quartile	III,IV	0.837	0.941	.010	12	view →
KIRC	DFS	Quartile	IV	0.511	0.649	.032	8	view →
KIRP	DFS	Median	III,IV	0.734	0.459	.010	7	view →
READ	OS	Quartile	III,IV	0.583	0.870	.021	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

TECRP2–OV (DFS)

Open the OV breakdown →